Loading provider…
Loading provider…
Dermatology Physician in Dallas, TX
NPI: 1154379188Primary Practice Location
Dermatology Treatment & Research Center, PA
5310 Harvest Hill Rd, Dallas, TX
Primary Employer
Bare Dermatology
barederm.com
HQ Phone
Get M.D. William's Phone Numberphone_androidMobile
Get M.D. William's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardTX State Medical License
TX State Medical License
1989 - 2025
OK State Medical License
1976 - 1990

American Board of Dermatology
Dermatology
UCLA David Geffen School of Medicine/UCLA Medical Center
Residency • Dermatology
1977 - 1979
Residency • Internal Medicine
1976 - 1977
University of Texas Health Science Center at Houston
Residency • Internal Medicine
1974 - 1975
Internship • Transitional Year
1973 - 1974
Central University of Venezuela
Medical School
Until 1972
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99213Established patient office or other outpatient visit, typically 15 minutes | 39 | 57 |
| 2 | 17110Destruction of up to 14 skin growths | 28 | 38 |
| 3 | 17000Destruction of skin growth | 26 | 34 |
| 4 | 99214Established patient office or other outpatient visit, 30-39 minutes | 21 | 35 |
| 5 | 99203New patient outpatient visit, total time 30-44 minutes | 21 | 21 |
Xyzal (levocetirizine dihydrochloride)
Authors: Abramovits, William, Gupta, Aditya
Journal: Skinmed
Treating Alopecia Areata: Current Practices Versus New Directions
Authors: Gupta, Aditya K, Carviel, Jessie, Abramovits, William
Journal: Am J Clin Dermatol
Authors: Aditya Gupta
Journal: Skinmed
Lead Sponsor: ASLAN Pharmaceuticals
Intervention / Treatment: DRUG: Placebo Comparator, BIOLOGICAL: ASLAN004
Lead Sponsor: Asana BioSciences
Intervention / Treatment: DRUG: ASN002
Lead Sponsor: Asana BioSciences
Intervention / Treatment: DRUG: Placebo Oral Tablet, DRUG: ASN002